120 related articles for article (PubMed ID: 36585204)
1. Serum CCL7 Is a Novel Prognostic Biomarker of Metastatic Colorectal Cancer.
Chidimatsu H; Tsunedomi R; Nakagami Y; Xu M; Nakajima M; Nakashima-Nakasuga C; Tomochika S; Yoshida S; Suzuki N; Watanabe Y; Matsui H; Shindo Y; Tokumitsu Y; Iida M; Takeda S; Ioka T; Ueno T; Tanabe T; Hoshii Y; Hazama S; Nagano H
Anticancer Res; 2023 Jan; 43(1):105-114. PubMed ID: 36585204
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of related factors of prognosis after surgical treatment of patients with non-metastatic colorectal cancer and construction of a normagram prediction model].
Liu SX; Zhang L; Shi YK; Han XH
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):167-172. PubMed ID: 35184461
[No Abstract] [Full Text] [Related]
3. Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab.
Nissen NI; Kehlet S; Boisen MK; Liljefors M; Jensen C; Johansen AZ; Johansen JS; Erler JT; Karsdal M; Mortensen JH; Høye A; Willumsen N
Sci Rep; 2021 Jan; 11(1):865. PubMed ID: 33441622
[TBL] [Abstract][Full Text] [Related]
4. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
[TBL] [Abstract][Full Text] [Related]
6. Correlation Between Baseline Osteoprotegerin Serum Levels and Prognosis of Advanced-Stage Colorectal Cancer Patients.
De Toni EN; Nagel D; Philipp AB; Herbst A; Thalhammer I; Mayerle J; Török HP; Brandl L; Kolligs FT
Cell Physiol Biochem; 2018; 45(2):605-613. PubMed ID: 29402836
[TBL] [Abstract][Full Text] [Related]
7. Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer.
He WZ; Guo GF; Yin CX; Jiang C; Wang F; Qiu HJ; Chen XX; Rong RM; Zhang B; Xia LP
Colorectal Dis; 2013 Aug; 15(8):e443-52. PubMed ID: 23621885
[TBL] [Abstract][Full Text] [Related]
8. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen kinetics predict response to first-line treatment in metastatic colorectal cancer: Analysis from PRODIGE 9 trial.
Salfati D; Huot M; Aparicio T; Lepage C; Taieb J; Bouché O; Boige V; Phelip JM; Dahan L; Bennouna J; Le Malicot K; Boussari O; Gornet JM
Dig Liver Dis; 2023 Jun; 55(6):791-798. PubMed ID: 36725401
[TBL] [Abstract][Full Text] [Related]
10. Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer.
Prager GW; Braemswig KH; Martel A; Unseld M; Heinze G; Brodowicz T; Scheithauer W; Kornek G; Zielinski CC
Cancer Sci; 2014 Aug; 105(8):996-1001. PubMed ID: 24850362
[TBL] [Abstract][Full Text] [Related]
11. Clinical validity of tissue carcinoembryonic antigen expression as ancillary to serum carcinoembryonic antigen concentration in patients curatively resected for colorectal cancer.
Park JW; Chang HJ; Kim BC; Yeo HY; Kim DY
Colorectal Dis; 2013 Sep; 15(9):e503-11. PubMed ID: 23711333
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of changes in systemic inflammatory markers and carcinoembryonic antigen levels in predicting metastatic colorectal cancer prognosis and chemotherapy response.
Kim IH; Lee JE; Yang JH; Jeong JW; Ro S; Lee MA
Asia Pac J Clin Oncol; 2018 Jun; 14(3):239-246. PubMed ID: 29044941
[TBL] [Abstract][Full Text] [Related]
13. Palliative resection of the primary tumour improves survival in incurable metastatic colorectal cancer.
Inci K; Nilsson B; Lindskog S; Giglio D
ANZ J Surg; 2023 Nov; 93(11):2680-2685. PubMed ID: 37489624
[TBL] [Abstract][Full Text] [Related]
14. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of preoperative serum markers for individual patient prognosis in stage I-III rectal cancer.
Giessen C; Nagel D; Glas M; Spelsberg F; Lau-Werner U; Modest DP; Michl M; Heinemann V; Stieber P; Schulz C
Tumour Biol; 2014 Oct; 35(10):10237-48. PubMed ID: 25027407
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic Antigen-related Tumor Kinetics After Eight Weeks of Chemotherapy is Independently Associated With Overall Survival in Patients With Metastatic Colorectal Cancer.
Colloca GA; Venturino A; Guarneri D
Clin Colorectal Cancer; 2020 Dec; 19(4):e200-e207. PubMed ID: 32952072
[TBL] [Abstract][Full Text] [Related]
17. Comparison of carcinoembryonic antigen prognostic value in serum and tumour tissue of patients with colorectal cancer.
Li M; Li JY; Zhao AL; He JS; Zhou LX; Li YA; Gu J
Colorectal Dis; 2009 Mar; 11(3):276-81. PubMed ID: 18513194
[TBL] [Abstract][Full Text] [Related]
18. Serum Ferritin as a Prognostic Biomarker for Survival in Relapsed or Refractory Metastatic Colorectal Cancer.
Lee S; Song A; Eo W
J Cancer; 2016; 7(8):957-64. PubMed ID: 27313786
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome.
Thomsen M; Skovlund E; Sorbye H; Bolstad N; Nustad KJ; Glimelius B; Pfeiffer P; Kure EH; Johansen JS; Tveit KM; Christoffersen T; Guren TK
Br J Cancer; 2018 Jun; 118(12):1609-1616. PubMed ID: 29872151
[TBL] [Abstract][Full Text] [Related]
20. TIMP-1 and CEA as biomarkers in third-line treatment with irinotecan and cetuximab for metastatic colorectal cancer.
Spindler KL; Christensen IJ; Nielsen HJ; Jakobsen A; Brünner N
Tumour Biol; 2015 Jun; 36(6):4301-8. PubMed ID: 25608838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
